We are live on ! Find out more
CYTK icon

Cytokinetics

134 hedge funds and large institutions have $315M invested in Cytokinetics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 132134 (+2)

7% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 46

2.32% less ownership

Funds ownership: 73.92%71.59% (-2.3%)

38% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.99M

45% less capital invested

Capital invested by funds: $575M → $315M (-$261M)

Holders
134
Holders Change
+2
Holders Change %
+1.52%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
43
Reduced
46
Closed
21
Calls
$1.24M
Puts
$1.99M
Net Calls
-$754K
Net Calls Change
-$3.51M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
51
Wells Fargo
California
$589K +$247K +21,724 +43%
Canada Life
52
Canada Life
Manitoba, Canada
$540K
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$534K -$11K -967 -1%
Swiss National Bank
54
Swiss National Bank
Switzerland
$531K
Comerica Bank
55
Comerica Bank
Texas
$499K -$17.8K -1,566 -3%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$428K
PCM
57
Prelude Capital Management
New York
$378K +$120K +10,534 +29%
Bank of America
58
Bank of America
North Carolina
$362K -$372K -32,730 -42%
VEA
59
Virtus ETF Advisers
New York
$348K +$219K +19,250 +82%
VFA
60
Virtus Fund Advisers
Connecticut
$348K +$484K +42,645 New
WMSA
61
Weiss Multi-Strategy Advisers
New York
$326K -$568K -50,000 -56%
State of Tennessee, Department of Treasury
62
State of Tennessee, Department of Treasury
Tennessee
$322K -$15.1K -1,333 -3%
ProShare Advisors
63
ProShare Advisors
Maryland
$299K +$30.3K +2,670 +8%
SCA
64
Secor Capital Advisors
New York
$291K +$405K +35,697 New
TPSF
65
Texas Permanent School Fund
Texas
$279K -$29.4K -2,590 -7%
AIG
66
American International Group
New York
$278K +$1.8K +159 +0.5%
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$273K +$10.7K +944 +3%
Public Sector Pension Investment Board (PSP Investments)
68
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$263K
LCM
69
Landscape Capital Management
New Jersey
$263K +$366K +32,237 New
CS
70
Credit Suisse
Switzerland
$262K -$250K -21,981 -41%
Thrivent Financial for Lutherans
71
Thrivent Financial for Lutherans
Minnesota
$255K +$6.99K +616 +2%
State of Wisconsin Investment Board
72
State of Wisconsin Investment Board
Wisconsin
$244K
Group One Trading
73
Group One Trading
Illinois
$239K -$417K -36,693 -56%
AQR Capital Management
74
AQR Capital Management
Connecticut
$219K +$14.9K +1,310 +5%
Los Angeles Capital Management
75
Los Angeles Capital Management
California
$218K -$322K -28,339 -51%

CYTK Hedge Fund Activity: Q4 2017 in Review

134 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2017, worth a combined $315M — down 45% from $575M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 21 closed out — a net gain of 3 holders — while 43 added to existing stakes and 46 trimmed.

The largest buyer was BVF Inc, adding an estimated $50.9M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $40.3M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q4 2017, up from 132 in Q3 2017.
  • Funds reported $315M of Cytokinetics stock for Q4 2017, down 45% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q4 2017 and 21 closed out, a net change of +3 holders.
  • The largest Cytokinetics buyer in Q4 2017 was BVF Inc, an estimated $50.9M added.
  • The largest Cytokinetics seller in Q4 2017 was Janus Henderson Group, an estimated $40.3M sold.

Based on aggregated 13F filings for Q4 2017.